[Survey of the antibiotic sensitivity of Pseudomonas aeruginosa in France and the distribution of beta-lactam resistance mechanisms: the GERPB 1999 study].
D000046:Academic Medical Centers / Q000706:statistics & numerical data; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics*; D002510:Cephalosporinase / Q000235:genetics; D002511:Cephalosporins / Q000494:pharmacology; D002876:Chromosomes, Bacterial / Q000235:genetics; D004351:Drug Resistance / Q000235:genetics; D005602:France / Q000453:epidemiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D011446:Prospective Studies; D011552:Pseudomonas Infections / Q000453:epidemiology / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000145:classification / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification; D011815:R Factors / Q000235:genetics; D012703:Serotyping; D001618:beta-Lactamases / Q000235:genetics*
Surveillance de la sensibilité de Pseudomonas aeruginosa aux antibiotiques en France et distribution des mécanismes de résistance aux bêtalactamines: étude GERPB 1999.